{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0030154",
      "entity_text" : "differentiation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04866",
      "entity_text" : "muM Icaritin",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Treatment with 1 muM Icaritin upregulated osteocalcin, RUNX family transcription factor 2, tissue-nonspecific alkaline phosphatase and beta-catenin, and suppressed sclerostin (SOST) gene expression in different stages of osteogenic differentiation.",
  "reading_complete" : "2020-08-03T18:10:33Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T18:09:57Z",
  "trigger" : "suppressed",
  "evidence" : [ "muM Icaritin upregulated osteocalcin, RUNX family transcription factor 2, tissue-nonspecific alkaline phosphatase and beta-catenin, and suppressed sclerostin (SOST) gene expression in different stages of osteogenic differentiation" ],
  "pmc_id" : "7015123",
  "score" : 0
}